A celebration of the inspirational figures behind innovation and achievement in pathology and laboratory medicine
09/21/2017 | Joanna Cummings
When it comes to identifying cancerous tissue, is the “MasSpec Pen” mightier than the sword?
09/21/2017 | Michael Schubert
A newly validated clinical assay can detect gene fusions that lead to cancer
09/21/2017 | Roisin McGuigan
The International Mesothelioma Interest Group has issued updated guidelines for diagnosis
08/21/2017 | Josephine Bunch
Meet the researchers using mass spectrometry imaging to plot a molecular map of malignancy
08/21/2017 | Alberto Bardelli
Liquid biopsy allows cancer investigation without applying invasive procedures to patients
08/18/2017 | Dominic Allen
Biobanks can operate efficiently and successfully by learning from the automotive industry
08/18/2017 | Roisin McGuigan
Nanopore and plasmonic technology could speed diagnosis of pancreatic cancer
Could an existing blood test improve treatment choices – and outcomes – in colon cancer?
08/18/2017
What is the most likely diagnosis for this lung tumor removed from a 50-year-old man?
07/20/2017 | Roisin McGuigan
Eleftherios P. Diamandis, Hold ’em for Life Chair in Prostate Cancer Biomarkers, University of Toronto.
Register to access our FREE online portfolio, request the magazine in print and manage your preferences.
Register
Lessons from the Power List: Challenges
The Genome Pioneer
The Value of Neuropathology